Drug interactions for the following drug(s)
Applies to: Ondansetron 4 MG Oral Tablet <> Dramamine 50 MG Chewable Tablet
The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Dimenhydrinate.
Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.
Applies to: Ondansetron 4 MG Oral Tablet <> Dramamine 50 MG Chewable Tablet
Drug1 (rxcui = 198052, name = Ondansetron 4 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 602223, name = Dimenhydrinate 50 MG Chewable Tablet [Dramamine], tty = SBD). Drug1 is resolved to Dimenhydrinate, Drug2 is resolved to Ondansetron and interaction asserted in DrugBank between Dimenhydrinate and Ondansetron.
Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.